Stay updated on HepTcell Immunotherapy in Inactive CHB Clinical Trial

Sign up to get notified when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HepTcell Immunotherapy in Inactive CHB Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision notice updated from v3.3.3 to v3.3.4; no trial details, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T05:01:01.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The Locations section is updated to add regional entries (California, Alberta, Ontario, Missouri, Oklahoma) and remove the separate location groupings, with the revision updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-17T19:49:56.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Results-related updates were added, including 'Results First Posted (Estimated)' on 2025-12-04 and associated results submission milestones. New and updated outcomes are listed, such as virologic response, serologic clearance of HBsAg and HBV DNA on Day 169, and changes in HBV markers and immune responses.
    Difference
    2%
    Check dated 2025-12-10T19:11:22.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 label on the page, replacing Revision: v3.2.0. This appears to be a system update and does not modify study details or other user-visible content.
    Difference
    0.1%
    Check dated 2025-11-26T13:53:30.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Removed the site-wide notice about funding-related delays and operating status. The page now presents only trial-specific details and status.
    Difference
    0.4%
    Check dated 2025-11-18T22:50:40.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The new screenshot shows minor adjustments to layout and styling without altering core study details such as the title, status, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:54:53.000Z thumbnail image

Stay in the know with updates to HepTcell Immunotherapy in Inactive CHB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.